86 related articles for article (PubMed ID: 8117524)
1. [The pharmacology and clinical aspects of the prostanoids].
Ambrosioni E; Degli Esposti D
Ann Ital Med Int; 1993 Oct; 8 Suppl():59S-65S. PubMed ID: 8117524
[TBL] [Abstract][Full Text] [Related]
2. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
Heidrich H
Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin releasing polymers - stability and efficacy.
McRea JC; Ebert CD; Kim SW
Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
[TBL] [Abstract][Full Text] [Related]
4. Possibilities for clinical use of prostacyclin in vascular disease.
Poredos P
Pflugers Arch; 2000; 440(5 Suppl):R137-8. PubMed ID: 11005643
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease.
Schrör K; Hohlfeld T
Vasa; 2004 Aug; 33(3):119-24. PubMed ID: 15461062
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine.
Ylä-Herttuala S; Rissanen TT; Vajanto I; Hartikainen J
J Am Coll Cardiol; 2007 Mar; 49(10):1015-26. PubMed ID: 17349880
[TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular effects of prostacyclin].
Chaignon M; Guelpa G; Lucsko M; Guédon J
Nouv Presse Med; 1982 Dec; 11(50):3717-21. PubMed ID: 6763197
[TBL] [Abstract][Full Text] [Related]
8. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
de Donato G; Gussoni G; de Donato G
Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
[TBL] [Abstract][Full Text] [Related]
9. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
10. [Special aspects of therapy of non-atherosclerotic vascular diseases].
Schellong SM
Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):645-9. PubMed ID: 10666828
[TBL] [Abstract][Full Text] [Related]
11. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.
Grant SM; Goa KL
Drugs; 1992 Jun; 43(6):889-924. PubMed ID: 1379160
[TBL] [Abstract][Full Text] [Related]
12. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
[No Abstract] [Full Text] [Related]
13. Review: recent advances in lipid microsphere technology for targeting prostaglandin delivery.
Mizushima Y; Hoshi K
J Drug Target; 1993; 1(2):93-100. PubMed ID: 8069557
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease.
Sinzinger H; Virgolini I; O'Grady J
Prog Clin Biol Res; 1989; 301():85-96. PubMed ID: 2477859
[No Abstract] [Full Text] [Related]
15. An antagonist of prostaglandin synthesis in cardiovascular diseases.
Viinikka L
Ann Clin Res; 1984; 16(5-6):262-8. PubMed ID: 6398664
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of peripheral vascular disease: are there new perspectives?
Smit AJ
Vasa Suppl; 1992; 34():20-4. PubMed ID: 1529413
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of generalized anxiety: new pharmacologic approaches].
Boulenger JP
Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
[TBL] [Abstract][Full Text] [Related]
18. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
Scheffler A; Rieger H
Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
[TBL] [Abstract][Full Text] [Related]
19. Prospects of prostanoid therapy. Preliminary results.
Castagno PL; Di Molfetta L; Merlo M; Barile G; Violato F; Buzzacchino A; Ponzio F
Minerva Cardioangiol; 2000; 48(1-2):9-18. PubMed ID: 10829583
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefits of iloprost, a stable prostacyclin (PGI2) analog, in severe peripheral arterial disease (PAD).
Oberender H; Krais T; Schäfer M; Belcher G
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():311-6. PubMed ID: 2473610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
